糖尿病的血管并发症：损伤机制和保护因素。
Vascular complications of diabetes: mechanisms of injury and protective factors.
机构信息
Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
出版信息
Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012.
Abstract
In patients with diabetes, atherosclerosis is the main reason for impaired life expectancy, and diabetic nephropathy and retinopathy are the largest contributors to end-stage renal disease and blindness, respectively. An improved therapeutic approach to combat diabetic vascular complications might include blocking mechanisms of injury as well as promoting protective or regenerating factors, for example by enhancing the action of insulin-regulated genes in endothelial cells, promoting gene programs leading to induction of antioxidant or anti-inflammatory factors, or improving the sensitivity to vascular cell survival factors. Such strategies could help prevent complications despite suboptimal metabolic control.
摘要
在糖尿病患者中，动脉粥样硬化是导致预期寿命缩短的主要原因，而糖尿病肾病和视网膜病变分别是导致终末期肾病和失明的最大原因。改善治疗方法以对抗糖尿病血管并发症可能包括阻断损伤机制以及促进保护或再生因子，例如通过增强内皮细胞中胰岛素调节基因的作用、促进导致诱导抗氧化或抗炎因子的基因程序，或改善对血管细胞存活因子的敏感性。即使代谢控制不理想，这些策略也有助于预防并发症。
相似文献
1
Vascular complications of diabetes: mechanisms of injury and protective factors.糖尿病的血管并发症：损伤机制和保护因素。
Cell Metab. 2013 Jan 8;17(1):20-33. doi: 10.1016/j.cmet.2012.11.012.
2
Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.聚（ADP - 核糖）聚合酶激活在糖尿病肾病、神经病变和视网膜病变中的作用。
Curr Vasc Pharmacol. 2005 Jul;3(3):267-83. doi: 10.2174/1570161054368634.
3
The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.氧化应激在糖尿病神经病变中的作用：糖基化反应中自由基的产生以及编码抗氧化酶的基因多态性与I型糖尿病患者群体对糖尿病神经病变的遗传易感性
Cell Biochem Biophys. 2015 Apr;71(3):1425-43. doi: 10.1007/s12013-014-0365-y.
4
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.糖尿病血管并发症：病理生理学、生化基础及潜在治疗策略。
Curr Pharm Des. 2005;11(18):2279-99. doi: 10.2174/1381612054367300.
5
Oxidative stress in diabetic nephropathy.糖尿病肾病中的氧化应激。
Curr Med Chem. 2010;17(34):4256-69. doi: 10.2174/092986710793348581.
6
Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy.PEDF 介导的对抗糖尿病视网膜病变和神经病变中活性氧损伤的保护机制。
J Endocrinol. 2014 Sep;222(3):R129-39. doi: 10.1530/JOE-14-0065. Epub 2014 Jun 13.
7
Diabetic nephropathy--prevalence, complications and treatment.糖尿病肾病——患病率、并发症及治疗
Diabet Med. 1985 Jan;2(1):7-12. doi: 10.1111/j.1464-5491.1985.tb00584.x.
8
Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.晚期糖基化终末产物（AGEs）和氧化应激在糖尿病视网膜病变中的作用。
Curr Pharm Des. 2008;14(10):962-8. doi: 10.2174/138161208784139729.
9
Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.色素上皮衍生因子（PEDF）：其在糖尿病血管并发症中的潜在治疗意义。
Curr Drug Targets. 2008 Nov;9(11):1025-9. doi: 10.2174/138945008786786154.
10
Clinical diabetic nephropathy: natural history and complications.临床糖尿病肾病：自然病史与并发症
Clin Endocrinol Metab. 1986 Nov;15(4):783-805. doi: 10.1016/s0300-595x(86)80074-3.
引用本文的文献
1
Noninvasive Assessment of Arterial Wall and Soluble ST2 in Patients with Type 2 Diabetes and Coronary Artery Disease.2型糖尿病合并冠状动脉疾病患者动脉壁及可溶性ST2的无创评估
Int J Mol Sci. 2025 Aug 5;26(15):7561. doi: 10.3390/ijms26157561.
2
Daidzein alleviates renal damage in streptozotocin induced diabetes in Sprague Dawley rats by targeting NOX-4 and RAC-1.大豆苷元通过作用于NOX-4和RAC-1减轻链脲佐菌素诱导的Sprague Dawley大鼠糖尿病肾损伤。
J Mol Histol. 2025 Aug 12;56(5):266. doi: 10.1007/s10735-025-10430-6.
3
Relations of Life's Essential 8 Score with Arterial and Microvascular Function: The Jackson Heart Study.生命必需8分与动脉和微血管功能的关系：杰克逊心脏研究
medRxiv. 2025 Aug 3:2025.08.01.25332660. doi: 10.1101/2025.08.01.25332660.
4
Novel Function for Endothelial Protease-Activated Receptors in Modulating Insulin Receptor Activity With Implications for Diabetes.内皮蛋白酶激活受体在调节胰岛素受体活性中的新功能及其对糖尿病的影响。
Arterioscler Thromb Vasc Biol. 2025 Jul 31. doi: 10.1161/ATVBAHA.125.323140.
5
Cardiometabolic risk phenotypes and chronic kidney disease incidence in older adults: a nationwide longitudinal cohort study.老年人心血管代谢风险表型与慢性肾脏病发病率：一项全国性纵向队列研究
BMC Public Health. 2025 Jul 29;25(1):2581. doi: 10.1186/s12889-025-23868-w.
6
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.治疗性血浆置换：减轻疾病中细胞信号传导的当前及新兴应用
Biomolecules. 2025 Jul 12;15(7):1000. doi: 10.3390/biom15071000.
7
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress.糖尿病诱导的大血管和微血管并发症的病理生理机制：氧化应激的作用
Med Sci (Basel). 2025 Jul 2;13(3):87. doi: 10.3390/medsci13030087.
8
Facile 3-chloro-1H-indazole based 1,3,4-thiadiazole derivatives as novel thymidine phosphorylase and anti-diabetic inhibitors: Experimental, in-vitro and molecular modelling approaches.基于3-氯-1H-吲唑的简便1,3,4-噻二唑衍生物作为新型胸苷磷酸化酶和抗糖尿病抑制剂：实验、体外及分子模拟方法
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 19. doi: 10.1007/s00210-025-04385-4.
9
Facile indazole-endowed thiadiazole hybrid derivatives as antibacterial, anti-diabetic and thymidine phosphorylase inhibitors: An insight to experimental, in-vitro biological potential and computational approaches.简便的吲唑基噻二唑杂化衍生物作为抗菌、抗糖尿病和胸苷磷酸化酶抑制剂：对实验、体外生物学潜力和计算方法的深入研究
Saudi Pharm J. 2025 Jul 8;33(4):20. doi: 10.1007/s44446-025-00003-9.
10
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes.2型糖尿病患者血糖风险指数与颈动脉内膜中层厚度的关联
Front Endocrinol (Lausanne). 2025 Jun 19;16:1563734. doi: 10.3389/fendo.2025.1563734. eCollection 2025.
本文引用的文献
1
Vegfa protects the glomerular microvasculature in diabetes.Vegfa 可保护糖尿病患者的肾小球微血管。
Diabetes. 2012 Nov;61(11):2958-66. doi: 10.2337/db11-1655.
2
Wip1-dependent regulation of autophagy, obesity, and atherosclerosis.Wip1 依赖性自噬、肥胖和动脉粥样硬化的调控。
Cell Metab. 2012 Jul 3;16(1):68-80. doi: 10.1016/j.cmet.2012.06.003.
3
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.心血管系统中 NADPH 氧化酶的生物化学、生理学和病理生理学。
Circ Res. 2012 May 11;110(10):1364-90. doi: 10.1161/CIRCRESAHA.111.243972.
4
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.肾小球血管内皮生长因子抵抗由蛋白激酶 Cδ/含Src 同源区 2 结构域蛋白酪氨酸磷酸酶 1 激活诱导，并有助于糖尿病肾病发生。
FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12.
5
Diabetic retinopathy.糖尿病视网膜病变
N Engl J Med. 2012 Mar 29;366(13):1227-39. doi: 10.1056/NEJMra1005073.
6
Macrophage autophagy plays a protective role in advanced atherosclerosis.巨噬细胞自噬在动脉粥样硬化的进展中发挥保护作用。
Cell Metab. 2012 Apr 4;15(4):545-53. doi: 10.1016/j.cmet.2012.01.022. Epub 2012 Mar 22.
7
Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.蛋白激酶 Cβ磷酸化紧密连接蛋白 occludin 调节血管内皮生长因子诱导的体内通透性的紧密连接转运。
Diabetes. 2012 Jun;61(6):1573-83. doi: 10.2337/db11-1367. Epub 2012 Mar 20.
8
Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.高胰岛素血症不会改变载脂蛋白 E 基因敲除小鼠的动脉粥样硬化发展。
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1124-31. doi: 10.1161/ATVBAHA.111.239558. Epub 2012 Mar 15.
9
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.系统方法确定 HIPK2 是肾脏纤维化的关键调节因子。
Nat Med. 2012 Mar 11;18(4):580-8. doi: 10.1038/nm.2685.
10
FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.FoxOs 整合胰岛素在血管内皮中的多效作用，以保护小鼠免受动脉粥样硬化的侵害。
Cell Metab. 2012 Mar 7;15(3):372-81. doi: 10.1016/j.cmet.2012.01.018.
Zotero 插件